𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclooxygenase-2 polymorphisms in Parkinson's disease

✍ Scribed by Anna Håkansson; Olle Bergman; Cecilia Chrapkowska; Lars Westberg; Andrea Carmine Belin; Olof Sydow; Bo Johnels; Lars Olson; Björn Holmberg; Hans Nissbrandt

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
61 KB
Volume
144B
Category
Article
ISSN
1552-4841

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of LINGO1 polymorphisms in Parkinso
Role of LINGO1 polymorphisms in Parkinson's disease
✍ Dietrich Haubenberger; Christoph Hotzy; Walter Pirker; Regina Katzenschlager; Th 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB 👁 1 views

## Abstract A clinical overlap between Parkinson's disease (PD) and essential tremor (ET) has prompted a discussion whether these conditions share common genetic susceptibility factors. Recently, the first genome‐wide association study in ET revealed a significant association with a variant in the

Genetic polymorphisms of superoxide dism
Genetic polymorphisms of superoxide dismutase in Parkinson's disease
✍ Federico M. Farin; Yolanda Hitosis; Sarah E. Hallagan; John Kushleika; James S. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 22 KB

## Abstract Oxidative stress reactions may contribute to the pathogenesis of Parkinson's disease (PD). The superoxide dismutases potentially play significant roles in PD by detoxifying superoxide radical. We developed genomic DNA and cDNA‐based sequencing assays to identify genetic variants in the

Dopamine D2 receptor TaqIA and TaqIB pol
Dopamine D2 receptor TaqIA and TaqIB polymorphisms in Parkinson's disease
✍ Eng-King Tan; Yanni Tan; Anthea Chai; Christopher Tan; Hui Shen; Sau-Ying Lum; S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

## Abstract In a case control study, we examined the association of DRD2 Taq1A and Taq1B polymorphisms and risk of PD, and evaluated the strength of linkage disequilibrium of the polymorphisms. The Taq1A and Taq1B polymorphisms were in strong linkage disequilibrium. There was, however, no significa

CYP2D6 polymorphism in Parkinson's disea
CYP2D6 polymorphism in Parkinson's disease: The Rotterdam study
✍ B. Sanjay Harhangi; Ben A. Oostra; Peter Heutink; Cornelia M. van Duijn; Albert 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB

## Abstract The CYP2D6 polymorphism has been studied extensively in association with Parkinson's disease (PD), with no consistent results. Several explanations, such as differences in study design or bias in the selection of the control population, have been offered for these inconsistent results.